Skip to main content
Top

Breast Cancer

Issue 2/2008

Content (12 Articles)

Conference Paper

Breast cancer: individualized diagnosis for tailored treatment

Hideo Inaji, Futoshi Akiyama

Conference Paper

Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging

Hiroko Tsunoda-Shimizu, Naoki Hayashi, Tsuyoshi Hamaoka, Tomonori Kawasaki, Koichiro Tsugawa, Hiroshi Yagata, Mari Kikuchi, Koyu Suzuki, Seigo Nakamura

Conference Paper

Personalized systemic treatment for breast cancer patients: is it a reality?

Chikako Shimizu, Yasuhiro Fujiwara

Conference Paper

In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine

Motohiro Takeda, Hiroshi Tada, Hideo Higuchi, Yoshio Kobayashi, Masaki Kobayashi, Yuu Sakurai, Takanori Ishida, Noriaki Ohuchi

Original Article

Screening ultrasonography revealed 15% of mammographically occult breast cancers

Ken Uchida, Akinori Yamashita, Kazumi Kawase, Kentarou Kamiya

Original Article

Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer?

Shinji Ozaki, Mitsuhiro Tozaki, Eisuke Fukuma, Naoko Kawano, Takako Suzuki, Norie Yamashiro, Masaaki Sakamoto, Tomoko Tsuruhara, Naomi Sakamoto, Kuniki Higa, Satoko Abe, Tomoko Ogawa, Yuko Tsunoda, Katayama Nobuhito

Case Report

A case of malignant eccrine spiradenoma metastatic to intramammary lymph node

Yuko Tanaka, Ekapot Bhunchet, Toshikatsu Shibata

Case Report

Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors

Daisuke Takabatake, Naruto Taira, Kenjiro Aogi, Shozo Ohsumi, Shigemitsu Takashima, Takeshi Inoue, Rieko Nishimura

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine